Detalhe da pesquisa
1.
Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma.
N Engl J Med
; 384(14): 1289-1300, 2021 04 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33616314
2.
AI-Assisted chemical probe discovery for the understudied Calcium-Calmodulin Dependent Kinase, PNCK.
PLoS Comput Biol
; 19(5): e1010263, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-37235579
3.
Correction: AI-Assisted chemical probe discovery for the understudied Calcium-Calmodulin Dependent Kinase, PNCK.
PLoS Comput Biol
; 19(11): e1011672, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37992014
4.
A plain language summary exploring a new treatment combination for untreated locally advanced or metastatic urothelial cancer: enfortumab vedotin plus pembrolizumab.
Future Oncol
; 20(7): 351-360, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37994649
5.
Belzutifan plus cabozantinib for patients with advanced clear cell renal cell carcinoma previously treated with immunotherapy: an open-label, single-arm, phase 2 study.
Lancet Oncol
; 24(5): 553-562, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37011650
6.
Lenvatinib plus pembrolizumab versus sunitinib as first-line treatment of patients with advanced renal cell carcinoma (CLEAR): extended follow-up from the phase 3, randomised, open-label study.
Lancet Oncol
; 24(3): 228-238, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36858721
7.
Characterization and Management of Adverse Reactions From the CLEAR Study in Advanced Renal Cell Carcinoma Treated With Lenvatinib Plus Pembrolizumab.
Oncologist
; 28(6): 501-509, 2023 06 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36866412
8.
A phase 1b study of the Notch inhibitor crenigacestat (LY3039478) in combination with other anticancer target agents (taladegib, LY3023414, or abemaciclib) in patients with advanced or metastatic solid tumors.
Invest New Drugs
; 39(4): 1089-1098, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33686452
9.
Axitinib plus pembrolizumab in patients with advanced sarcomas including alveolar soft-part sarcoma: a single-centre, single-arm, phase 2 trial.
Lancet Oncol
; 20(6): 837-848, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31078463
10.
Percutaneous Image-Guided Irreversible Electroporation for the Treatment of Unresectable, Locally Advanced Pancreatic Adenocarcinoma.
J Vasc Interv Radiol
; 28(3): 342-348, 2017 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-27993507
11.
Pazopanib versus sunitinib in metastatic renal-cell carcinoma.
N Engl J Med
; 369(8): 722-31, 2013 Aug 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-23964934
12.
In vivo anti-metastatic effects of uPAR retargeted measles virus in syngeneic and xenograft models of mammary cancer.
Breast Cancer Res Treat
; 149(1): 99-108, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25519042
13.
Full dose neoadjuvant FOLFIRINOX is associated with prolonged survival in patients with locally advanced pancreatic adenocarcinoma.
Pancreatology
; 15(6): 667-73, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26412296
14.
Phase I LITESPARK-001 study of belzutifan for advanced solid tumors: Extended 41-month follow-up in the clear cell renal cell carcinoma cohort.
Eur J Cancer
; 196: 113434, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38008031
15.
Lenvatinib Plus Pembrolizumab Versus Sunitinib in First-Line Treatment of Advanced Renal Cell Carcinoma: Final Prespecified Overall Survival Analysis of CLEAR, a Phase III Study.
J Clin Oncol
; 42(11): 1222-1228, 2024 Apr 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38227898
16.
Combined histone deacetylase and cyclooxygenase inhibition achieves enhanced antiangiogenic effects in lung cancer cells.
Mol Carcinog
; 52(3): 218-28, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-22121107
17.
Fatty acid metabolism reprogramming in ccRCC: mechanisms and potential targets.
Nat Rev Urol
; 20(1): 48-60, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36192502
18.
Enfortumab Vedotin Plus Pembrolizumab in Previously Untreated Advanced Urothelial Cancer.
J Clin Oncol
; 41(1): 22-31, 2023 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36041086
19.
Phase 1, open-label, dose-escalation study on the safety, pharmacokinetics, and preliminary efficacy of intravenous Coxsackievirus A21 (V937), with or without pembrolizumab, in patients with advanced solid tumors.
J Immunother Cancer
; 11(1)2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36669791
20.
A retrospective study of neoadjuvant FOLFIRINOX in unresectable or borderline-resectable locally advanced pancreatic adenocarcinoma.
BMC Cancer
; 12: 199, 2012 May 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-22642850